1004 / 1068
HIV & ANAL CANCER
Historically ( pre-HAART ) anal carcinoma
treatment in HIV positive patients associated with
lower response rate and reduced survival
Radiotherapy and chemotherapy poorly tolerated
with more toxicity and breaks in treatment
More recent studies ( post HAART ) suggest
outcomes equivalent to non-HIV+ patients